West Pharmaceutical Services (WST) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

West Pharmaceutical Services Revenue Highlights

Latest Revenue (Y)

$2.95B

Latest Revenue (Q)

$746.90M

Main Segment (Y)

Proprietary Products

Main Geography (Y)

UNITED STATES

West Pharmaceutical Services Revenue by Period

West Pharmaceutical Services Revenue by Year

Date	Revenue	Change
2023-12-31	$2.95B	2.18%
2022-12-31	$2.89B	1.95%
2021-12-31	$2.83B	31.89%
2020-12-31	$2.15B	16.69%
2019-12-31	$1.84B	7.13%
2018-12-31	$1.72B	7.40%
2017-12-31	$1.60B	5.96%
2016-12-31	$1.51B	7.81%
2015-12-31	$1.40B	-1.52%
2014-12-31	$1.42B	3.87%
2013-12-31	$1.37B	8.05%
2012-12-31	$1.27B	6.21%
2011-12-31	$1.19B	7.93%
2010-12-31	$1.10B	4.64%
2009-12-31	$1.06B	0.44%
2008-12-31	$1.05B	3.04%
2007-12-31	$1.02B	11.69%
2006-12-31	$913.30M	30.53%
2005-12-31	$699.70M	29.19%
2004-12-31	$541.60M	10.37%
2003-12-31	$490.70M	16.92%
2002-12-31	$419.70M	5.74%
2001-12-31	$396.90M	-7.72%
2000-12-31	$430.10M	-8.31%
1999-12-31	$469.10M	4.31%
1998-12-31	$449.70M	-0.62%
1997-12-31	$452.50M	-1.37%
1996-12-31	$458.80M	11.12%
1995-12-31	$412.90M	13.09%
1994-12-31	$365.10M	4.70%
1993-12-31	$348.70M	-

West Pharmaceutical Services generated $2.95B in revenue during NA 2023, up 2.18% compared to the previous quarter, and up 171.76% compared to the same period a year ago.

West Pharmaceutical Services Revenue by Quarter

Date	Revenue	Change
2024-09-30	$746.90M	6.40%
2024-06-30	$702.00M	0.95%
2024-03-31	$695.40M	-5.00%
2023-12-31	$732.00M	-2.06%
2023-09-30	$747.40M	-0.85%
2023-06-30	$753.80M	5.19%
2023-03-31	$716.60M	1.11%
2022-12-31	$708.70M	3.17%
2022-09-30	$686.90M	-10.94%
2022-06-30	$771.30M	7.13%
2022-03-31	$720.00M	-1.48%
2021-12-31	$730.80M	3.44%
2021-09-30	$706.50M	-2.36%
2021-06-30	$723.60M	7.89%
2021-03-31	$670.70M	15.60%
2020-12-31	$580.20M	5.88%
2020-09-30	$548.00M	3.95%
2020-06-30	$527.20M	7.26%
2020-03-31	$491.50M	4.44%
2019-12-31	$470.60M	3.18%
2019-09-30	$456.10M	-2.90%
2019-06-30	$469.70M	5.91%
2019-03-31	$443.50M	4.97%
2018-12-31	$422.50M	-2.13%
2018-09-30	$431.70M	-3.53%
2018-06-30	$447.50M	7.65%
2018-03-31	$415.70M	0.02%
2017-12-31	$415.60M	4.37%
2017-09-30	$398.20M	0.15%
2017-06-30	$397.60M	2.55%
2017-03-31	$387.70M	1.41%
2016-12-31	$382.30M	1.49%
2016-09-30	$376.70M	-2.91%
2016-06-30	$388.00M	7.15%
2016-03-31	$362.10M	0.67%
2015-12-31	$359.70M	4.41%
2015-09-30	$344.50M	-4.23%
2015-06-30	$359.70M	7.09%
2015-03-31	$335.90M	-3.97%
2014-12-31	$349.80M	-1.71%
2014-09-30	$355.90M	-3.52%
2014-06-30	$368.90M	6.37%
2014-03-31	$346.80M	1.20%
2013-12-31	$342.70M	0.26%
2013-09-30	$341.80M	-0.78%
2013-06-30	$344.50M	1.50%
2013-03-31	$339.40M	5.57%
2012-12-31	$321.50M	5.83%
2012-09-30	$303.80M	-6.47%
2012-06-30	$324.80M	2.69%
2012-03-31	$316.30M	7.08%
2011-12-31	$295.40M	0.61%
2011-09-30	$293.60M	-4.64%
2011-06-30	$307.90M	4.23%
2011-03-31	$295.40M	6.72%
2010-12-31	$276.80M	1.99%
2010-09-30	$271.40M	-3.69%
2010-06-30	$281.80M	2.58%
2010-03-31	$274.70M	-6.37%
2009-12-31	$293.40M	13.33%
2009-09-30	$258.90M	-0.80%
2009-06-30	$261.00M	7.67%
2009-03-31	$242.40M	-0.98%
2008-12-31	$244.80M	-4.45%
2008-09-30	$256.20M	-8.27%
2008-06-30	$279.30M	3.18%
2008-03-31	$270.70M	5.70%
2007-12-31	$256.10M	-

West Pharmaceutical Services generated $746.90M in revenue during Q3 2024, up 6.40% compared to the previous quarter, and up 99.08% compared to the same period a year ago.

West Pharmaceutical Services Revenue Breakdown

West Pharmaceutical Services Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Proprietary Products	$2.40B	$2.41B	$2.32B	$1.65B	$1.40B
Contract Manufactured Products	$552.50M	$480.40M	$514.70M	$498.60M	$441.50M
Corporate and Eliminations	-	-	-	-	$-200.00K

West Pharmaceutical Services's latest annual revenue breakdown by segment (product or service), as of Dec 23: Proprietary Products (81.27%), and Contract Manufactured Products (18.73%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18
Contract Manufactured Products	$145.50M	$142.40M	$135.90M	$419.00M	$133.50M	$118.70M	$127.10M	-	-	-	-	-	-	-	-	-	-	-	-	-
Proprietary Products	-	-	-	$1.81B	$583.10M	$601.30M	$543.70M	-	-	-	-	-	-	-	-	-	-	-	-	-
Delivery Systems	-	-	-	-	$144.90M	$135.80M	$120.00M	$117.80M	$129.70M	$136.40M	$126.60M	$127.80M	$118.10M	$111.10M	$109.40M	$103.10M	$106.70M	-	-	-
Packaging Systems	-	-	-	-	$602.50M	$567.00M	$653.70M	$577.00M	$587.30M	$421.50M	$399.50M	$373.50M	$345.20M	$360.30M	$340.40M	$325.20M	-	-	-	-
Intersegment Eliminations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-100.00K	$-200.00K	$-200.00K	-	-

West Pharmaceutical Services's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Contract Manufactured Products (100.00%).

West Pharmaceutical Services Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
GERMANY	$406.10M	$398.70M	$474.30M	$282.10M	$236.30M
FRANCE	$282.90M	$237.90M	$213.00M	$172.70M	$150.60M
UNITED STATES	$1.24B	$1.29B	$1.20B	$975.60M	$814.70M
Other Europe Countries	$388.10M	$359.20M	$341.30M	$236.80M	$251.10M
Other Countries	$348.50M	$364.30M	$357.40M	$253.70M	$213.40M
IRELAND	$285.70M	$240.30M	$247.60M	$226.00M	$173.80M

West Pharmaceutical Services's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (41.99%), GERMANY (13.77%), Other Europe Countries (13.16%), Other Countries (11.81%), IRELAND (9.69%), and FRANCE (9.59%).

West Pharmaceutical Services Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BDX	Becton, Dickinson and Company	$20.18B	$4.99B
BAX	Baxter	$14.81B	$3.81B
ALC	Alcon	$10.09B	$2.46B
RMD	ResMed	$4.69B	$1.22B
HOLX	Hologic	$4.03B	$1.01B
COO	Cooper Companies	$3.90B	$1.00B
TFX	Teleflex	$2.97B	$764.38M
WST	West Pharmaceutical Services	$2.95B	$746.90M
ICUI	ICU Medical	$2.26B	$589.13M
HAE	Haemonetics	$1.31B	$336.17M
MMSI	Merit Medical Systems	$1.26B	$339.85M
EMBC	Embecta	$1.12B	$272.50M
RGEN	Repligen	$638.76M	$141.19M

WST Revenue FAQ

What is West Pharmaceutical Services’s yearly revenue?

West Pharmaceutical Services's yearly revenue for 2023 was $2.95B, representing an increase of 2.18% compared to 2022. The company's yearly revenue for 2022 was $2.89B, representing an increase of 1.95% compared to 2021. WST's yearly revenue for 2021 was $2.83B, representing an increase of 31.89% compared to 2020.

What is West Pharmaceutical Services’s quarterly revenue?

West Pharmaceutical Services's quarterly revenue for Q3 2024 was $746.9M, a 6.40% increase from the previous quarter (Q2 2024), and a -0.07% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $702M, a 0.95% increase from the previous quarter (Q1 2024), and a -6.87% decrease year-over-year (Q2 2023). WST's quarterly revenue for Q1 2024 was $695.4M, a -5.00% decrease from the previous quarter (Q4 2023), and a -2.96% decrease year-over-year (Q1 2023).

What is West Pharmaceutical Services’s revenue growth rate?

West Pharmaceutical Services's revenue growth rate for the last 3 years (2021-2023) was 4.17%, and for the last 5 years (2019-2023) was 60.32%.

What are West Pharmaceutical Services’s revenue streams?

West Pharmaceutical Services's revenue streams in c 23 are Proprietary Products, and Contract Manufactured Products. Proprietary Products generated $2.4B in revenue, accounting 81.27% of the company's total revenue, down -0.39% year-over-year. Contract Manufactured Products generated $552.5M in revenue, accounting 18.73% of the company's total revenue, up 15.01% year-over-year.

What is West Pharmaceutical Services’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of West Pharmaceutical Services was Proprietary Products. This segment made a revenue of $2.4B, representing 81.27% of the company's total revenue.